SEC delays decision on VanEck spot Ethereum ETF, asks for public comments
In a document filed on Wednesday, the SEC said it would take until May 23, 2024 decide on whether to approve VanEck’s spot ether ETF and asked the public for comments. The delays come as the Ethereum Foundation said it received a voluntary and confidential inquiry from an unspecified state authority, according to reporting from The Block.
In a document filed on Wednesday, the agency said it would take until May 23, 2024 to make a decision on the ETF and asked the public for comments.
"The Commission finds that it is appropriate to designate a longer period within which to issue an order approving or disapproving the proposed rule change so that it has sufficient time to consider the proposed rule change, as modified by Amendment No. 1, and the issues raised therein," the SEC said.
This comes a day after the SEC delayed making a decision on the Hashdex Nasdaq Ethereum ETF and the ARK 21Shares Ethereum ETF.
Future of a spot Ethereum ETF looks iffy
Big-name firms, including Fidelity and BlackRock , have applied for a spot ether ETF over the last few months. Optimism for the SEC approving such a product has steadily fallen over the past few weeks. Bloomberg ETF analyst Eric Balchunas recently lowered his estimate of the chances of a spot Ethereum ETF approval by May from about 70 percent to 30 percent.
The delays come as the Ethereum Foundation said it received a voluntary and confidential inquiry from an unspecified state authority, according to reporting from The Block.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
Cardano’s x402 integration lets AI agents pay for APIs directly in ADA
